Inhibitory effects of budesonide/formoterol on extracellular matrix in TGFß1-stimulated bronchial biopsy fibroblasts from mild asthmatic patients Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Inhibitory effects of budesonide and formoterol in combination on TGFβ-induced proteoglycan production by bronchial biopsy fibroblasts from healthy and mild asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function Source: Eur Respir J 2008; 32: 989-996 Year: 2008
Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma Source: Eur Respir J 2003; 22: Suppl. 45, 285s Year: 2003
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Role of Pgp in corticosteroid sensitivity in patients with severe forms of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006
Transbronchial fibroblasts from mild asthmatics have different proteoglycan production and migratory properties compared to transbronchial fibroblasts from rhinitis patients Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007
Efficacy of symbicort administration in patients with bronchial asthma Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Symptoms, induced sputum eosinophil percentages and treatment with salmeterol or fluticasone in mild asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Combined treatment with fluticasone plus salmeterol protects against allergen induced asthmatic responses and subsequent increase in sputum eosinophils Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002
Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011
Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007
Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide Source: International Congress 2018 – Basic pharmacology Year: 2018
The evaluation of bone density in the patients with bronchial asthma treated with glucocorticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002